Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-175-8 | CAS number: 79-08-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January to July 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD, EPA, etc)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Version / remarks:
- a nd EU method B.11
- Deviations:
- yes
- Remarks:
- only males were used because no sex differences were found in a previous chromosomal aberration study performed with Bromoacetic acid (see TNO report V 90.215). In this study cytotoxicity was found in female rats.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Bromoacetic acid
- EC Number:
- 201-175-8
- EC Name:
- Bromoacetic acid
- Cas Number:
- 79-08-3
- Molecular formula:
- C2H3BrO2
- IUPAC Name:
- 2-bromoacetic acid
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Bromoacetic acid
- Substance type: White to yellow crystals
- Physical state: Solid
- Analytical purity: 96.6%
- Lot/batch No.: S4394760
- Stability under test conditions: Stable at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Germany
- Age at study initiation: 6 weeks
- Weight at study initiation: 151.5-179.3 g
- Assigned to test groups randomly: yes, under following basis: computer randomization
- Housing: The rats were housed with five per cage under conventional conditions in one room in sterilised macrolon cages (type IV), fitted with a grid cover of stainless steel and with a bedding od wood shavings (Lignocel). Enviro-dry was used as cage enrichment.
- Diet (e.g. ad libitum): ad libitum from the arrival of the animals until the end of the study.
- Water (e.g. ad libitum): ad libitum from the arrival of the animals until the end of the study.
- Acclimation period: yes, during this period the animals were observed daily for overt signs of ill health and anomalies.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/-3°C
- Humidity (%): 40% and not exceeding 70%
- Air changes (per hr): 10 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Controls: Yes
- Vehicle: Injection water - Details on exposure:
- DOSE RANGE FINDINGS STUDY was performed - step-wise approach
- Dosing volume of the test substance (20 ml/kg-bw).
- Observation: 1 h, 4 and 24 hours post treatment.
PREPARATION OF DOSING SOLUTIONS and DIET PREPARATION
Details not reported - Duration of treatment / exposure:
- Sacrifice:
- Group A (negative control) 24 h (5 males) and 48 h (5 males)
- Group B (monobromoacetic acid): 50 dose level (mg/kg bw) - 24 h (5 males)
- Group c (monobromoacetic acid): 100 dose level (mg/kg bw) - 24 h (5 males)
- Group D (monobromoacetic acid): 150 dose level (mg/kg bw) - 24 h (5 males) and 48 h (5 males)
- Group E (mytomycin C - positive control): 3.0 dose level (mg/kg bw) - 24 h (5 males)
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 50, 100, 150 mg/kg bw
Basis:
nominal in diet
monobromoacetic acid
- Remarks:
- Doses / Concentrations:
3.0 mg/kg bw
Basis:
nominal conc.
intraperitoneal injection of Mitomycin C
- No. of animals per sex per dose:
- 10 animals for control and high-dose, 5 animals for low- and mid-dose
- Control animals:
- yes
- Positive control(s):
- - Substance used as Positive Control: Mitomycin C, 3.0 mg/kg bw
- Vehicle: Positive: control by intraperitoneal injection
Examinations
- Tissues and cell types examined:
- - Clinical signs: Yes - 4 hours post-treatment
- Tissue: Bone marrow
- Number of animals: 5 animals/sex/group at each time point
- Number of cells: 20, 100, 200, 1000, 2000 or other
- Time points: 6, 24, 48 h after treatment
- Type of cells: bone marrow
- Parameters: numbers and types of structural aberrations and mitotic index - Details of tissue and slide preparation:
- After sacrifice, the femurs were dissected free of all adherent muscle and tissue. Bone marrow cells were removed from the femurs by flushing with Hank's balanced salt solution (HBBS), exposed to a hypotonic solution (0,075 M potassium chloride, pre-warmed to 37 °C), fixed in freshly prepared 3: 1 (v/v) mixture of methanol and glacial acetic acid and processed for chromosomal preparations.
The slide, were stained with a 2% Giemsa (Merck-Darmstadt, Darmstadt, Germany) solution, air-dried and embedded. Two slides per animal were prepared for both the mitotic index scoring and chromosomal aberration analysis. Two slides per animal were examined, One thousand cells, 500 cell per slide), were examined to determine the percentage of cells in mitosis (mitotic index). Of each animal, 100 well-spread metaphases (5-0 metaphases per slide), each containing 40-42 centromeres, were analysed by microscopic examination for both chromatid-type and chromosome-type aberration, and other anomalies such as endoreduplicated cells, polyploid cells or heavily damaged cells. Endoreduplicated cells, polyploid cells, and heavily damaged cells were recorded but not included in the 100 analysed cells per animal. The Vernier readings of all aberrant metaphase, observed were recorded. - Evaluation criteria:
- The Vernier readings of all aberrant metaphase
- Statistics:
- Data were analyzed by Analysis of Variance (ANOVA), after square root transformation (sqrt(x+1)) to 'normalise' the distribution of the counts (Lovell et al., 1989). If the ANOVA yielded significant results, pairwise comparisons between treated and control groups were made. Data were analyzed statistically by non-parametric Kruskal-Wallis ANOVA. At the time point 24 hours, data from groups A,B,C and D were subjected to Kruskal-Wallis one way ANOVA. Kruskal-Wallis ANOVA was applied to the negative control group A versus treatment groups B,C and D.
All statistical tests were performed using BMDP statistical software (W.J Dixon, BMDP Statistical Software Manual, University of California Press, Berkeley, 1992).
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- - In the high-dose group (150 mg/kg bw ), 7 out of 10 rats were found dead within 24 hours after treatment. It was decided to treat the two reserve
rats with a dose level of 125 mg/kg bw . These two rats also died after treatment. Because not enough surviving rats remained for both scheduled sacrifice time points, it was decided to sacrifice the 3 surviving rats of the high-dose group (150 mg/kg bw ) at 24 hours. The 5 negative
(injection water) control rats, assigned to sacrifice time point 48 hours, were euthanized, but not used for further analysis.
1) Dose range finding:
In the dose range finding toxicity test, dose levels between 50 and 300 mg/kg bw were administered to groups of 3 animals in a stepwise manner. Rats of the control group were treated in a similar way with the vehicle (injection water) only. Twenty-four hours after treatment, all animals were sacrificed and the mitotic index in bone marrow cells was determined. Severe clinical signs and mortality were found at 200 mg/kg bw and above. Dose levels of 50, 100 and 150 mg Bromoacetic acid/kg bw were selected for the chromosomal aberration study.
2) Chromosomal aberration study:
Compared to the control, a decrease in the mean mitotic index was observed at all dose levels analysed (50, 100 and 150 mg/kg bw), statistically significant at 50 and 150 mg/kg bw. This demonstrates that the test substance or metabolites thereof have reached the bone marrow and induced cytotoxicity to the bone marrow cells. None of the dose levels of the test substance (50, 100 and 150 mg/kg bw) induced a statistically significant increase in the number of cells with structural chromosomal aberrations, when compared to the concurrent negative control (injection water). This indicates that treatment with Bromoacetic acid does not result in clastogenicity to bone marrow cells of rats. The positive control substance mitomycin C induced the expected statistically significant increase in the incidence of structural chromosomal aberrations, demonstrating the validity of the test system.
From the results obtained in this in-vivo chromosomal aberration test, it is concluded that Bromoacetic acid, close to the lethal dose, was cytotoxic
to the bone marrow, but did not induce structural chromosomal aberrations in the bone marrow cells of male rats, under the conditions used in this study.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
From the results obtained in this in-vivo chromosomal aberration test, it is concluded that Bromoacetic acid, close to the lethal dose, reached the bone marrow and induced cytotoxicity to the bone marrow cells.
Bromoacetic acid did not induce structural chromosome aberrations in bone marrow cells of male rats under the conditions employed in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.